Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Bioavailability of Two Tablet Formulations of PF-07220060 and Effect of Food and Rabeprazole
NCT05923411Phase 1Completed
- Sponsor
- Pfizer
- Start
- Jul 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of atirmociclib (8 cohorts), sponsored by Pfizer. Primary endpoints: Area under the plasma concentration versus time curve from time zero to extrapolated infinite time and Maximum Observed Plasma Concentration. Started Jul 2023; status: completed.
02
Drugs
atirmociclib
Beyond the preview
Go deeper on NCT05923411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05923411.